+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Completed

All Genders
ID00001530

Long-Term Results of DDD Pacing in Obstructive Hypertrophic Cardiomyopathy

Led by National Heart, Lung, and Blood Institute (NHLBI) · Updated on 2008-03-04

120

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What this Trial Is About

DDD pacing improves symptoms and relieves LV outflow tract (LVOT) obstruction in most patients with hypertrophic cardiomyopathy (HCM). Notably, when pacing is temporarily discontinued, the beneficial effects of pacing are evident in sinus rhythm. The long term results of this novel therapy are, however, uncertain. We propose (1) to record the hemodynamic changes following \>4 years of pacing; and (2) to determine whether DDD pacing continues to be necessary in patients who have had a substantial relief of their LVOT obstruction. Patients who have had \>50% reduction in LVOT pressure gradients will be randomized to two pacing modalities: DDD at 70 beats per minute and AAI pacing at 70 beats per minute (DDD switched off), and reevaluated after a six-month period.

CONDITIONS

Brief Title

Long-Term Results of DDD Pacing in Obstructive Hypertrophic Cardiomyopathy

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here